dihexa cancer risk hgf c-met safety concerns HGF/c-MET pathway in cancer: from molecular characterization to clinical evidence Targeting HGF/c-MET signaling to regulate – Downstream signalling and specific inhibition

How often are injections typically administered

This page keeps those checks inside the product flow instead of a generic article wall

It was first isolated from the cerebral venous blood of rabbits in 1977 by Schoenenberger and Monnier, following electrical stimulation of the thalamus during sleep induction experiments giving rise to its name

Research Applications & Usage Information Dihexa (8 mg) is commonly used for: HGF/c-Met receptor pathway studies Neurobiology and synaptic signaling research Cellular communication and growth factor signaling analysis Molecular pathway modeling in preclinical systems Investigations into receptor-binding and intracellular signaling Experimental studies of peptide-derived small molecule analogs All applications are investigational and intended for laboratory research use only